Ionis Pharmaceuticals IONS Interest Paid, Excluding Capitalized Interest, Operating Activity
Interest Paid, Excluding Capitalized Interest, Operating Activity at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's interest paid, excluding capitalized interest, operating activity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's interest paid, excluding capitalized interest, operating activity?
- Ionis Pharmaceuticals (IONS) reported interest paid, excluding capitalized interest, operating activity of $90K in Q1 2026.
- How has Ionis Pharmaceuticals's interest paid, excluding capitalized interest, operating activity changed year-over-year?
- Ionis Pharmaceuticals's interest paid, excluding capitalized interest, operating activity decreased by 2.2% year-over-year, from $92K to $90K.
- What is the long-term trend for Ionis Pharmaceuticals's interest paid, excluding capitalized interest, operating activity?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's interest paid, excluding capitalized interest, operating activity has grown at a 22.6% compound annual growth rate (CAGR), from $4.78M to $10.78M.